The 2nd BioLink
Highlights: A multi-dimensional interactive platform-Keynote speeches+ panel discussions+
project showcase+ exhibition Authoritative trend analysis of Chinese biopharmaceutical industry-analysis on
landscape of therapeutic biologics on a global scale A comprehensive showcase of internationally-leading biopharma technologies-
immunotherapy+ precision medicine+ R&D and production of therapeutic biologics A detailed guide to decision-making of venture capital-great financing opportunities
for biotech start-ups An array of projects promotion towards tech transfer, financing and M&A The greatest occasion to meet 200+ industry players
AGENDA
DAY ONE DAY TWO
9:00-12:00 Meeting:Module 1
Exhibition
9:00-10:30 Meeting:Module 5
Exhibition 13:30-15:30 Meeting:Module 2 10:50-12:00
Project Showcase:
Module 6 15:50-18:30 Parallel Meetings:Module 3-4
Chairperson:Mr. Xia Mingde, Senior Director of New Ventures, Johnson & Johnson Innovation
DAY 1:DEC.1, 2015
Module 1: Industry Development and Updates on Regulatory Policies and Standards
Areas to be covered: Latest regulatory policies, assessment, standards and case studies
9:00 -9:10
Opening Address from Chairman
Xia Mingde, Senior Director of New Ventures, Johnson & Johnson Innovation
9:10 -9:40
Opening Keynote
Xu Ming, Vice President, CCCMHPIE
9:40 -10:10
Building an innovation-driven ecosystem for bio-pharma industry in China
Joseph Cho, Managing Director, RDPAC
10:10 -10:40
China's Health Policy and Progress in Industry innovation
John Cai, Director, Center for Healthcare Management and Policy of CEIBS
10:40 -11:10
Regulating Therapeutic Biologics-A View Of Chinese New Pharmacopeia
Official, Chinese Pharmacopoeia Commission
11:10 -11:30
Tea Break and Networking
Visit the exhibition area and to network with 200+ industrial peers
11:30 -12:00
Keynote David Flores, CEO, BioCentury
12:00 -13:30
Lunch
Module 2: Global Biopharmaceutical Market Dynamics
13:30 -14:00
Regulation Of Biosimilars In the EU And Case Studies
-European Medicines Agency (TBC)
14:00 -14:30
Key Consideration on Biologicals Review and Case Studies
-FDA
14:30 -15:00
Overview of Biologics Standard Development at United States Pharmacopeia
-Bingbing Feng, Vice President and General Manager, USP-China
15:00 -15:30
Biopharmaceutical Product Strategies on a Global Scale in 2015
-Zhou Feng, Product & Solution Specialist, Thomson Reuters
15:30 -15:50
Tea Break and Networking
Visit the exhibition area and to network with 200+ industrial peers
15:50 -18:30
Parallel Sessio
n
Module 3: Immune therapy and Precision Medicine
Module 4: R&D and Production of Therapeutic Biologics
Areas to be covered: Immunology, Precision, Innovation, Clinical Moderator:
Xu Ming, Vice President, CCCMHPIE Keynote speakers: Wang Hongqi,Vice President,BGI Li Kang, Head of Biologics, BeiGene Panelists: - Wang Hongqi,Vice President,BGI -Li Kang, Head of Biologics, BeiGene -Mr. Wang Yinxiang, Chief scientist and CEO,Betta Pharmaceuticals -Wu Zhuoyan, Vice President, Beijing SL Pharmaceutical -Zhang Lianshan, Jiangsu Hengrui Medicine
Co.,Ltd. (TBC) -Expert, Beijing Cancer Hospital (TBC)
Areas to be covered: R&D, Manufacturing process, Expression, Trend Moderator:
Xia Mingde, Senior Director of New Ventures, Johnson & Johnson Innovation Keynote speakers: -Qiu Xiaobo, Professor, College of Life Sciences, Beijing Normal University -Dr. Tian Feng, CSO, Ambrx Panelists: -Qiu Xiaobo, Professor, College of Life Sciences, Beijing Normal University -Mr. Tian Feng, CFO, Ambrx -Julius Li, CEO, AutekBio China, Inc- Boehringer-Ingelheim China
-Merck (TBC) -Roche (TBC) -CELLTRION (TBC)
DAY 2:DEC.2, 2015
9:00 -10:00
Module 5: Biopharmaceuticals and Financing
Areas to be covered:Discovery, Technology, Capital, Integration
Speakers to be invited:
-Che Yan, CSO, Bayer China
-Liu Xin, Managing Director, China office of Greater Pacific Capital China
-Sylvia He, Partner, CDH Venture
-Yin Jinqun, Vice President, KangHong Pharmaceutical Group
-Shao Qun, Director Deputy Director, Open Innovation University of Bradford
- Cao Xiaochun, Deputy General Manager, Hangzhou Tigermed Consulting
- David Flores, CEO, BioCentury
10:00 -10:20
Tea Break and Networking
Visit the exhibition area and to network with 200+ industrial peers
10:20 -12:30
Module 6: Roadshow
Highlights of well selected Chinese and overseas projects for technology transfer, financing
and M&A